Alkaloids Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 06-12-2024
- Paid Up Capital ₹ 2.00 M
as on 06-12-2024
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.50 Cr
as on 06-12-2024
- Revenue 14.65%
(FY 2023)
- Profit 4.89%
(FY 2023)
- Ebitda 25.61%
(FY 2023)
- Net Worth 13.84%
(FY 2023)
- Total Assets 18.55%
(FY 2023)
About Alkaloids
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹15.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manoj Karnani, Karnani Kumar, Sanjay Karnani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24114WB1992PTC054233
- Company No.
054233
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 1992
- Date of AGM
22 Jan 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alkaloids?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Karnani  | Director | 03-Dec-2022 | Current |
| Karnani Kumar | Director | 03-Nov-2022 | Current |
| Sanjay Karnani | Director | 03-Dec-2022 | Current |
| Manish Karnani | Director | 03-Dec-2022 | Current |
Financial Performance and Corporate Structure Insights of Alkaloids.
Alkaloids Pvt Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 14.65% increase. The company also saw a slight improvement in profitability, with a 4.89% increase in profit. The company's net worth Soared by an impressive increase of 13.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alkaloids?
In 2023, Alkaloids had a promoter holding of 0.10% and a public holding of 99.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alkaloids Bioactives Private LimitedActive 1 year 6 monthsManoj Karnani, Karnani Kumar and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Oct 2020 | ₹4.50 Cr | Satisfied |
Citibank N.A Creation Date: 05 Mar 2009 | ₹11.00 Cr | Satisfied |
How Many Employees Work at Alkaloids?
Alkaloids has a workforce of 177 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alkaloids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alkaloids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
